(Q36537083)
Statements
1 reference
Is there a cardiovascular rationale for the use of combined vasopressin V1a/V2 receptor antagonists? (English)
1 reference
Steven R Goldsmith
1 reference
1 July 2006
1 reference
1 reference
119
1 reference
7 Suppl 1
1 reference
S93-6
1 reference
Identifiers
1 reference
1 reference